BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 36286956)

  • 1. Clinical factors associated with noncurative endoscopic submucosal dissection for the expanded indication of intestinal-type early gastric cancer: Post hoc analysis of a multi-institutional, single-arm, confirmatory trial (JCOG0607).
    Kadota T; Hasuike N; Ono H; Boku N; Mizusawa J; Oda I; Oyama T; Horiuchi Y; Hirasawa K; Yoshio T; Minashi K; Takizawa K; Nakamura K; Muto M
    Dig Endosc; 2023 May; 35(4):494-502. PubMed ID: 36286956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A non-randomized confirmatory trial of an expanded indication for endoscopic submucosal dissection for intestinal-type gastric cancer (cT1a): the Japan Clinical Oncology Group study (JCOG0607).
    Hasuike N; Ono H; Boku N; Mizusawa J; Takizawa K; Fukuda H; Oda I; Doyama H; Kaneko K; Hori S; Iishi H; Kurokawa Y; Muto M;
    Gastric Cancer; 2018 Jan; 21(1):114-123. PubMed ID: 28224238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors associated with technical difficulty of endoscopic submucosal dissection for early gastric cancer that met the expanded indication criteria: post hoc analysis of a multi-institutional prospective confirmatory trial (JCOG0607).
    Yano T; Hasuike N; Ono H; Boku N; Ogawa G; Kadota T; Oda I; Doyama H; Hori S; Iishi H; Takahashi A; Takizawa K; Muto M
    Gastric Cancer; 2020 Jan; 23(1):168-174. PubMed ID: 31321630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A nonrandomized, single-arm confirmatory trial of expanded endoscopic submucosal dissection indication for undifferentiated early gastric cancer: Japan Clinical Oncology Group study (JCOG1009/1010).
    Takizawa K; Ono H; Hasuike N; Takashima A; Minashi K; Boku N; Kushima R; Katayama H; Ogawa G; Fukuda H; Fujisaki J; Oda I; Yano T; Hori S; Doyama H; Hirasawa K; Yamamoto Y; Ishihara R; Tanabe S; Niwa Y; Nakagawa M; Terashima M; Muto M;
    Gastric Cancer; 2021 Mar; 24(2):479-491. PubMed ID: 33161444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feasibility of endoscopic treatment and predictors of lymph node metastasis in early gastric cancer.
    Chu YN; Yu YN; Jing X; Mao T; Chen YQ; Zhou XB; Song W; Zhao XZ; Tian ZB
    World J Gastroenterol; 2019 Sep; 25(35):5344-5355. PubMed ID: 31558878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Predictive factors for lymph node metastasis in patients with poorly differentiated early gastric cancer].
    Pang BR; Zhu ZL; Li C; Liu WT; KumarSah RD; Yan M; Zhu ZG
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 May; 22(5):446-450. PubMed ID: 31104430
    [No Abstract]   [Full Text] [Related]  

  • 7. Indication for endoscopic treatment based on the risk of lymph node metastasis in patients with undifferentiated early gastric cancer.
    Liang XQ; Wang Z; Li HT; Ma G; Yu WW; Zhou HC; Liu HB
    Asian J Surg; 2020 Oct; 43(10):973-977. PubMed ID: 31964584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Efficacy comparison between surgical resection and endoscopic submucosal dissection of early gastric cancer in a domestic single center].
    Rong L; Cai Y; Nian W; Wang X; Liang J; He Y; Zhang J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Feb; 21(2):190-195. PubMed ID: 29492919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymph node metastasis from intestinal-type early gastric cancer: experience in a single institution and reassessment of the extended criteria for endoscopic submucosal dissection.
    Kang HJ; Kim DH; Jeon TY; Lee SH; Shin N; Chae SH; Kim GH; Song GA; Kim DH; Srivastava A; Park DY; Lauwers GY
    Gastrointest Endosc; 2010 Sep; 72(3):508-15. PubMed ID: 20554277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical outcomes of minimally invasive treatment for early gastric cancer in patients beyond the indications of endoscopic submucosal dissection.
    Ko WJ; Kim YM; Yoo IK; Cho JY
    Surg Endosc; 2018 Sep; 32(9):3798-3805. PubMed ID: 29464402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term outcomes of endoscopic submucosal dissection versus surgery in early gastric cancer meeting expanded indication including undifferentiated-type tumors: a criteria-based analysis.
    Lee S; Choi KD; Han M; Na HK; Ahn JY; Jung KW; Lee JH; Kim DH; Song HJ; Lee GH; Yook JH; Kim BS; Jung HY
    Gastric Cancer; 2018 May; 21(3):490-499. PubMed ID: 29052052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term outcomes after endoscopic submucosal dissection for differentiated-type early gastric cancer that fulfilled expanded indication criteria: A prospective cohort study.
    Shichijo S; Uedo N; Kanesaka T; Ohta T; Nakagawa K; Shimamoto Y; Ohmori M; Arao M; Iwatsubo T; Suzuki S; Matsuno K; Iwagami H; Inoue S; Matsuura N; Maekawa A; Nakahira H; Yamamoto S; Takeuchi Y; Higashino K; Ishihara R; Fukui K; Ito Y; Narahara H; Ishiguro S; Iishi H
    J Gastroenterol Hepatol; 2021 Mar; 36(3):664-670. PubMed ID: 32663347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endoscopic Indication of Endoscopic Submucosal Dissection for Early Gastric Cancer Is Not Compatible with Pathologic Criteria in Clinical Practice.
    Jeon SW; Park HW; Kwon YH; Nam SY; Lee HS
    Dig Dis Sci; 2019 Feb; 64(2):373-381. PubMed ID: 30311155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pretreatment risk factors for endoscopic noncurative resection of gastric cancers with undifferentiated-type components.
    Horiuchi Y; Takizawa K; Yoshio T; Mizusawa J; Ono H; Hasuike N; Yano T; Yoshida N; Miwa H; Boku N; Terashima M; Muto M
    J Gastroenterol Hepatol; 2022 Apr; 37(4):758-765. PubMed ID: 35168294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endoscopic submucosal dissection for papillary early gastric carcinoma: Insights from a large-scale analysis of post-gastrectomy pathology specimens.
    Lee JH; Oh JY; Kim YI; Lee JY; Kim CG; Choi IJ; Ryu KW; Kim YW; Cho SJ
    Medicine (Baltimore); 2022 Dec; 101(50):e32085. PubMed ID: 36550814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative predictors of beyond endoscopic submucosal dissection indication or lymphovascular invasion in endoscopic resection for early gastric cancer.
    Kim SJ; Choi CW; Kang DH; Kim HW; Park SB; Nam HS; Ryu DG
    Surg Endosc; 2018 Jun; 32(6):2948-2957. PubMed ID: 29280013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinico-pathologic determinants of non-e-curative outcome following en-bloc endoscopic submucosal dissection in patients with early gastric neoplasia.
    Embaye KS; Zhang C; Ghebrehiwet MA; Wang Z; Zhang F; Liu L; Qin S; Qin L; Wang J; Wang X
    BMC Cancer; 2021 Jan; 21(1):92. PubMed ID: 33482761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term outcomes of endoscopic submucosal dissection for early gastric cancer: a single-center experience.
    Choi MK; Kim GH; Park DY; Song GA; Kim DU; Ryu DY; Lee BE; Cheong JH; Cho M
    Surg Endosc; 2013 Nov; 27(11):4250-8. PubMed ID: 23765426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for submucosal and lymphovascular invasion in gastric cancer looking indicative for endoscopic submucosal dissection.
    Yamada T; Sugiyama H; Ochi D; Akutsu D; Suzuki H; Narasaka T; Moriwaki T; Endo S; Kaneko T; Satomi K; Ikezawa K; Mizokami Y; Hyodo I
    Gastric Cancer; 2014 Oct; 17(4):692-6. PubMed ID: 24323063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Additional laparoscopic gastrectomy after noncurative endoscopic submucosal dissection for early gastric cancer: A single-center experience.
    Tian YT; Ma FH; Wang GQ; Zhang YM; Dou LZ; Xie YB; Zhong YX; Chen YT; Xu Q; Zhao DB
    World J Gastroenterol; 2019 Aug; 25(29):3996-4006. PubMed ID: 31413533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.